Showing results (1311-1320 of 1,365) with videos related to

Sort By:
Pageof 137
Plos One|December 8, 2022
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical centerHeather B Root, Matt Gilleskie, Chih-Huan Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
A role for NPY-NPY2R signaling in albuminuric kidney diseaseAbigail C Lay, A Fern Barrington, Jenny A Hurcombe, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Nature Communications|July 28, 2017
AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationMichael C Haffner, David M Esopi, Alcides Chaux, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Cell Death & Disease|February 11, 2023
RIPK3 controls MAIT cell accumulation during development but not during infectionTimothy Patton, Zhe Zhao, Xin Yi Lim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
MR1 presents vitamin B6-related compounds for recognition by MR1-reactive T cellsMitchell P McInerney, Wael Awad, Michael N T Souter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent developmentJoyce A O'Shaughnessy, Gary J Kelloff, Gary B Gordon, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Pageof 137